Artedrone

Artedrone is a MedTech company based in Paris, founded in 2017 by Truffle Capital. The company specializes in developing autonomous robotic solutions for interventional neuroradiology, focusing on improving stroke treatment through mechanical thrombectomy. Artedrone's mission is to enhance access to this critical procedure, aiming to simplify the expertise required for healthcare professionals to perform it. The company's flagship product, the Sasha system, is a microrobotic platform that integrates robotics and AI-driven navigation. It features magnetically actuated microrobots that navigate the brain's vascular system and utilizes digital twin technology to create a precise replica of a patient's anatomy. This innovative platform is designed for stroke treatment but also has potential applications in other neurovascular and cardiovascular procedures. Artedrone is actively raising funds to support its clinical development, with plans for pivotal trials and regulatory approval. The company targets hospitals and medical centers involved in interventional neuroradiology, aiming to democratize access to advanced stroke care and address the global challenges posed by stroke.

• Employees 20
• Founded 2017